An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Approved Blood Products

HAEGARDA

STN: BL 125606
Proper Name: C1 Esterase Inhibitor (Human)
Tradename: Haergada
Manufacturer: CSL Behring GmbH
Indication:

For the routine prophylaxis to prevent Hereditary Angioedema (HAE) attacks in adolescent and adult patients.

Product Information

Package Insert - HAEGARDA
Demographic Subgroup Information - C1 Esterase Inhibitor Subcutaneous (Human) [HAEGARDA]
Refer to Section 1.1 of the clinical reviewer memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.

Supporting Documents

Related Information

Top